Seladelpar Reduces Serum IL-31, Improves Pruritus in Patients with Primary Biliary Cholangitis
The post-hoc analysis of the phase 3 ENHANCE study provides the first published evidence of a correlation between decreases in IL-31, bile acids, and pruritus symptoms in PBC following treatment with an investigational agent.
Source: hcplive.com